[Advances of minimally invasive glaucoma surgery in the combined treatment of primary angle-closure glaucoma].
Zhonghua Yan Ke Za Zhi
; 58(1): 63-68, 2022 Jan 11.
Article
em Zh
| MEDLINE
| ID: mdl-34979797
Glaucoma is the leading irreversible blinding eye disease worldwide, and China has the largest amount of primary angle-closure glaucoma (PACG). To reduce blindness, the therapeutic evolution can play a role. With the technical development of minimally invasive glaucoma surgery (MIGS), the treatment of angle-closure glaucoma has been in a transformation. This article reviews the literatures related to the advances of MIGS in the combined treatment of PACG. The research findings show that MIGS may become one of the preferred surgical treatments for PACG in the future clinical management of glaucoma.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Glaucoma de Ângulo Fechado
/
Glaucoma
Limite:
Humans
País/Região como assunto:
Asia
Idioma:
Zh
Ano de publicação:
2022
Tipo de documento:
Article